liveparallel.comHealthcare / Other HealthcareFounded: 2014Funding to Date: $228.07MM
Founded in 2014, Parallel is a privately-held company with a focus on cannabis products and cannabis research and development. The mission of the organization is to improve quality of life through the use cannabinoids. Based in Atlanta, GA, the company focuses on all facets of the cannabis supply chain such as cultivation, production, distribution and retail. Parallel has additional facilities in Massachusetts, Florida, Texas, and Budapest, Hungary.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/27/2019 | Series D | $130.89MM | $xx.xx | $2.47B | Ed Brown | |
Price per Share
$xx.xx
Shares Outstanding
3,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ed Brown
|
||||||
08/06/2018 | Series C | $66.88MM | $xx.xx | $226.04MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
16,500,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
04/18/2017 | Series BB | $5MM | $xx.xx | $52.94MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,108,730
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
20.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
04/18/2017 | Series B | $21.17MM | $xx.xx | $52.94MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
15,356,358
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
20.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
11/08/2016 | Series A-1 | $185,000.00 | $xx.xx | $24.28MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
370,000
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
11/08/2016 | Series A-3 | $899,999.00 | $xx.xx | $24.28MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
95,300
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
6.9x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
11/08/2016 | Series A-2 | $1.05MM | $xx.xx | $24.28MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
604,100
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.3x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
11/08/2016 | Series A-4 | $2MM | $xx.xx | $24.28MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
216,000
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
6.7x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|